As of 2025-06-17, the Fair Value of Theravance Biopharma Inc (TBPH) is -29.17 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.75 USD, the upside of Theravance Biopharma Inc is -371.32%.
With the market price of 10.75 USD and our fair value calculation, Theravance Biopharma Inc (TBPH) is not a good investment. Investing in TBPH stocks now will result in a potential loss of 371.32%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -278.00 | -199.40 | 872.10 | -55.19 | -56.42 | 56.62 |
| YoY growth | -17.55% | 28.27% | 537.36% | -106.33% | -2.22% | 87.91% |
| Market Cap (mil) | 537.50 |
| P/E | |
| Forward P/E |
| EPS | -1.17 |
| Avg earnings growth rate | 87.91% |
| TTM earnings | -58.33 |